Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
- 31 May 1990
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 88 (5), 470-476
- https://doi.org/10.1016/0002-9343(90)90425-d
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- SPONTANEOUS PRODUCTION OF FIBRONECTIN BY ALVEOLAR MACROPHAGES IN PATIENTS WITH SCLERODERMAArthritis & Rheumatism, 1989
- A Clinical, Radiographic, and Physiologic Scoring System for the Longitudinal Assessment of Patients with Idiopathic Pulmonary Fibrosis1–3American Review of Respiratory Disease, 1986
- Evidence for Chronic Inflammation as a Component of the Interstitial Lung Disease Associated with Progressive Systemic SclerosisAmerican Review of Respiratory Disease, 1985
- Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosisAmerican Journal Of Medicine, 1984
- Lung Involvement in SclerodermaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1984
- Safety of Fiberoptic Bronchoalveolar Lavage in Evaluation of Interstitial Lung DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1981
- Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.Thorax, 1980
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.JCI Insight, 1977
- Survival with Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1971